CAPR- Capricor Therapeutics, Inc.

Name: Capricor Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Capricor Therapeutics, Inc. (CAPR) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. CAPR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Litvack Frank	50.0K	$1.48M	-
CEO	Marban Linda	50.0K	$1.48M	-
VP	Krasney Karen	22.5K	$667.1K	-
Dir	Kelliher Mike	15.5K	$459.6K	-
Dir	Musket David B	15.5K	$459.6K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 27, 2022	Musket David B60	Director	Sell	17,775	$4.44	$78,921.00	-30.3%	+30.6%	+12.0%
May 9, 2017	Manzo Louis	Director	Buy	10,000	$3.10	$31,000.00	+7.8%	-	-
May 9, 2017	Musket David B60	Director	Buy	25,000	$3.10	$77,500.00	New	-	-
May 9, 2017	Cedars Sinai Medical Center	10% Owner	Buy	1,145,161	$3.10	$3,549,999.10	+39.4%	-	-
Sep 21, 2016	Cedars Sinai Medical Center	10% Owner	Buy	312,500	$3.20	$1,000,000.00	+12.1%	-	-
Mar 16, 2016	St. John Edward A.	10% Owner	Buy	833,332	$2.40	$1,999,996.80	+97.9%	-	-
Mar 16, 2016	Gershell Leland	Chief Financial Officer	Buy	2,100	$2.40	$5,040.00	New	-	-
Mar 16, 2016	Krasney Karen	EVP, General Counsel	Buy	4,060	$2.40	$9,744.00	+57.2%	-	-
Mar 16, 2016	Marban Linda	Chief Executive Officer	Buy	10,152	$2.40	$24,364.80	+3.9%	-	-
Mar 16, 2016	Bergmann Anthony	Vice President Of Finance	Buy	2,030	$2.40	$4,872.00	New	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC